Ranbaxy Laboratories Ltd. (RBXY), India’s
biggest drugmaker, fell the most since May in Mumbai trading
after reporting the worst loss in 10 quarters because of foreign
exchange losses.
The 4.65 billion rupees ($93 million) net loss compares with a profit of 3.08 billion rupees a year earlier, Ranbaxy said in a statement today. The company, based near New Delhi, was expected to report 1.46 billion rupees in profit, according to the median estimate of 26 analysts compiled by Bloomberg. Read More
The 4.65 billion rupees ($93 million) net loss compares with a profit of 3.08 billion rupees a year earlier, Ranbaxy said in a statement today. The company, based near New Delhi, was expected to report 1.46 billion rupees in profit, according to the median estimate of 26 analysts compiled by Bloomberg. Read More
No comments:
Post a Comment